Speaker(s): 

Ankeet S. Bhatt, MD, MBA, ScM, Staff Member, Kaiser Permanente San Francisco - has reported the following disclosures: Novo Nordisk [Consultant/Advisor], AstraZeneca [Consultant/Advisor], Amgen [Consultant/Advisor]

Moderator(s): 

Eric Wright, PharmD, MPH, Staff Member, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• identify evidence-based therapies for patients with heart failure
• understand the role of pharmacists in implementing evidence-based therapies
• identify opportunities to scale care coordination and address chronic care during inpatient hospitalizations

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Daniel Longyhore, PharmD, EdD, BCACP; Eric Wright, PharmD, MPH; Melissa Kern, MPH and Lisabeth Karetsky, CPhT have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None